CI
Cingulate Inc
🇺🇸XNAS.CINGUnited StatesHealthcare
$5.18USDup +0.12 (+2.37%)OpenDelayed3:55 PM
Price$5.18+0.12 (+2.37%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US17248W3034
- CUSIP
- 17248W105
Company
- Employees
- 14
- Headquarters
- Kansas City, United States
- Website
- https://www.cingulate.com
- CEO
- Dr. Shane J. Schaffer Pharm.D.
Market
- Shares outstanding
- 14.5M
- Market cap
- $75.33M
Highlights
- Market cap
- $73.58M
- EPS LTM
- -$1.98calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -2.62calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$28.8M-52.37%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$20.94M-20.13%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.